|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/28 | |
| A61K 35/14 | |||
| C07K 16/46 | |||
| A61K 35/17 | |||
| A61N 5/10 | |||
| A61K 39/00 | |||
| A61K 39/395 | |||
| A61K 45/06 | |||
| C07K 16/30 | |||
| C07K 16/40 |
| (11) | Number of the document | 2964675 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14714473.7 |
| Date of filing the European patent application | 2014-03-05 | |
| (97) | Date of publication of the European application | 2016-01-13 |
| (45) | Date of publication and mention of the grant of the patent | 2018-06-20 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/020919 |
| Date | 2014-03-05 |
| (87) | Number | WO 2014/138306 |
| Date | 2014-09-12 |
| (30) | Number | Date | Country code |
| 201361772803 P | 2013-03-05 | US | |
| 201361775524 P | 2013-03-09 | US | |
| 201461928383 P | 2014-01-16 | US | |
| 201461941729 P | 2014-02-19 | US |
| (72) |
GOTTSCHALK, Stephen, M. G., US
SONG, Xiao-Tong, US
IWAHORI, Kota, US
VELASQUEZ, Mireya, Paulina, US
ABBOTT, Sterwart, US
|
| (73) |
Celgene Corporation,
86 Morris Avenue, Summit, NJ 07901,
US
Baylor College Of Medicine, One Baylor Plaza, Houston, TX 77030, US |
| (54) | ENGAGER CELLS FOR IMMUNOTHERAPY |
| ENGAGER CELLS FOR IMMUNOTHERAPY |